Onconova Therapeutics, Inc. | Business Contracts

Onconova Therapeutics, Inc. 2021 Incentive Compensation Plan, as Amended and Restated, as approved by stockholders (Filed With SEC on November 14, 2022)

Employment Agreement Amendment between Onconova Therapeutics, Inc. and Mark Guerin dated June 10, 2022 (Filed With SEC on June 13, 2022)

Form of Non-Qualified Stock Option Agreement (Filed With SEC on November 15, 2021)

Form of Restricted Stock Unit Agreement (Filed With SEC on November 15, 2021)

Underwriting Agreement, dated September 23, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on September 24, 2021)

Equity Distribution Agreement, dated as of August 20, 2021, between Onconova Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on August 20, 2021)

Employment Agreement, dated March 9, 2021, by and between Onconova Therapeutics, Inc. and Abraham N. Oler (Filed With SEC on August 16, 2021)

Employment Agreement, dated June 14, 2021, by and between Onconova Therapeutics, Inc. and Mark Stephen Gelder,M.D (Filed With SEC on August 16, 2021)

Amendment to Employment Agreement, dated as of March 18, 2021, by and between Onconova Therapeutics, Inc. and Steven M. Fruchtman, M.D (Filed With SEC on March 18, 2021)

Underwriting Agreement, dated February 10, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 12, 2021)

Form of Purchase Agreement, dated as of January 7, 2021, by and among Onconova Therapeutics, Inc. and the investors party thereto (Filed With SEC on January 8, 2021)

Form of Stock Appreciation Right Award Agreement (for Non-Employee Directors) (Filed With SEC on November 16, 2020)

Form of Stock Appreciation Right Award Agreement (Filed With SEC on July 10, 2020)

Form of Performance Stock Unit Award Agreement (Filed With SEC on July 10, 2020)

Description of the Company's Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 27, 2020)

Form of Securities Purchase Agreement, dated as of December 31, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on January 3, 2020)

Form of Placement Agent Warrant (Filed With SEC on January 3, 2020)

Distribution, License and Supply Agreement, dated as of December 18, 2019, by and between Onconova Therapeutics, Inc. and Specialised Therapeutics Asia Pte. Ltd (Filed With SEC on December 19, 2019)

Form of Investor Warrant (Filed With SEC on December 19, 2019)

Form of Placement Agent Warrant (Filed With SEC on December 19, 2019)

Form of Securities Purchase Agreement, dated as of December 17, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 19, 2019)

Form of Securities Purchase Agreement, dated as of December 6, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 10, 2019)

Form of Placement Agent Warrant (Filed With SEC on December 10, 2019)

Form of Investor Warrant (Filed With SEC on December 10, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 26, 2019)

Form of Common Warrant (Filed With SEC on November 26, 2019)

Form of Placement Agent Warrant (Filed With SEC on November 26, 2019)

Form of Securities Purchase Agreement, dated as of November 21, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on November 26, 2019)

Distribution, License and Supply Agreement, dated as of November 20, 2019, by and between Onconova Therapeutics, Inc. and Knight Therapeutics Inc (Filed With SEC on November 21, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 14, 2019)

Form of Placement Agent Warrant (Filed With SEC on November 14, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 14, 2019)

Form of Warrant (Filed With SEC on November 14, 2019)

Form of Amendment to Warrant, dated as of September 23, 2019 (Filed With SEC on November 12, 2019)

Form of Underwriter Warrant (Filed With SEC on November 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 12, 2019)

Form of Warrant (Filed With SEC on November 12, 2019)

Form of Underwriting Agreement (Filed With SEC on November 12, 2019)

Form of Securities Purchase Agreement, dated as of September 23, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on September 25, 2019)

Form of Placement Agent Warrant (Filed With SEC on September 25, 2019)

Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc (Filed With SEC on August 14, 2019)

Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and Abundant New Investments Ltd (Filed With SEC on August 14, 2019)

License and Collaboration Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc (Filed With SEC on August 14, 2019)

Sales Agreement, dated May 17, 2019, by and between Onconova Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on May 17, 2019)

Separation and Release Agreement, effective as of January 15, 2019, by and between Onconova Therapeutics, Inc. and Ramesh Kumar, Ph.D (Filed With SEC on January 15, 2019)

First Amendment to Underwriter Series A Convertible Preferred Stock Purchase Warrant, dated as of September 24, 2018 (Filed With SEC on November 14, 2018)

Employment Agreement, effective as of November 5, 2018, by and between the Company and Richard C. Woodman, M.D (Filed With SEC on November 14, 2018)

Amended and Restated Employment Agreement, effective as of June 19, 2018, by and between the Company and Steven M. Fruchtman, M.D (Filed With SEC on August 14, 2018)

Form of Nonqualified Stock Option Award Agreement under the Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan (Filed With SEC on July 30, 2018)

Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan (Filed With SEC on June 29, 2018)

Securities Purchase Agreement, dated as of March 2, 2018, by and between Onconova Therapeutics, Inc. and Pint Pharma GmbH (Filed With SEC on May 15, 2018)

License, Development and Commercialization Agreement, dated as of March 2, 2018, by and between Onconova Therapeutics, Inc. and Pint International SA (Filed With SEC on May 15, 2018)

Form of Pre-Funded Warrant (Filed With SEC on April 30, 2018)

Form of Lock-Up Waiver Agreement (Filed With SEC on April 30, 2018)

Underwriting Agreement, dated as of April 27, 2018 (Filed With SEC on April 30, 2018)

Form of Preferred Stock Warrant (Filed With SEC on April 30, 2018)

Form of Underwriting Agreement (Filed With SEC on April 26, 2018)

Form of Underwriting Agreement (Filed With SEC on April 25, 2018)

Form of Warrant (Filed With SEC on April 25, 2018)

Form of Pre-Funded Warrant (Filed With SEC on April 25, 2018)

Form of Preferred Stock Warrant (Filed With SEC on February 8, 2018)

Form of Pre-Funded Warrant (Filed With SEC on February 8, 2018)

Form of Underwriter Warrant (Filed With SEC on February 8, 2018)

Underwriting Agreement, dated as of February 8, 2018 (Filed With SEC on February 8, 2018)

Form of Underwriting Agreement (Filed With SEC on February 7, 2018)

Form of Warrants (Filed With SEC on February 7, 2018)

Form of Pre-Funded Warrants (Filed With SEC on February 7, 2018)

Form of Underwriter Warrant (Filed With SEC on February 7, 2018)

Placement Agency Agreement, dated as of November 9, 2017 (Filed With SEC on November 13, 2017)

2,476,190 Shares ONCONOVA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 24, 2017)

www.onconova.com (Filed With SEC on March 29, 2017)

ONCONOVA THERAPEUTICS, INC. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on December 5, 2016)

ONCONOVA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 15, 2016)

[FORM OF WARRANT CERTIFICATE] (Filed With SEC on August 15, 2016)

WARRANT AGREEMENT (Filed With SEC on August 15, 2016)

ONCONOVA THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT July 7, 2016 (Filed With SEC on July 13, 2016)

FORM OF WARRANT CERTIFICATE (Filed With SEC on July 1, 2016)

FORM OF WARRANT AGREEMENT (Filed With SEC on July 1, 2016)

ONCONOVA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 1, 2016)

ONCONOVA THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT , 2016 (Filed With SEC on June 29, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2016)

ONCONOVA THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM TERMINATION OF SALES AGREEMENT (Filed With SEC on January 6, 2016)

COMMON STOCK PURCHASE WARRANT ONCONOVA THERAPEUTICS, INC. (Filed With SEC on January 6, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 6, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 8, 2015)

PURCHASE AGREEMENT (Filed With SEC on October 8, 2015)

ONCONOVA THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on October 5, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 13, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 8, 2015)

375 Pheasant Run, Newtown, PA 18940Phone: 267 ###-###-#### Fax: 267 ###-###-#### EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2015)

Onconova Therapeutics, Inc. Shares (1) Common Stock ($0.01 par value) Underwriting Agreement (Filed With SEC on July 18, 2013)

CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on July 18, 2013)

CONFIDENTIAL (Filed With SEC on July 18, 2013)

Onconova Therapeutics, Inc. (96)